White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities

Jessica Alber; Suvarna Alladi; Hee Joon Bae; David A. Barton; Laurel A. Beckett; Joanne M. Bell; Sara E. Berman; Geert Jan Biessels; Sandra E. Black; Isabelle Bos; Gene L. Bowman; Emanuele Brai; Adam M. Brickman; Brandy L. Callahan; Roderick A. Corriveau; Silvia Fossati; Rebecca F. Gottesman; Deborah R. Gustafson; Vladimir Hachinski; Kathleen M. Hayden; Alex M. Helman; Timothy M. Hughes; Jeremy D. Isaacs; Angela L. Jefferson; Sterling C. Johnson; Alifiya Kapasi; Silke Kern; Jay C. Kwon; Juraj Kukolja; Athene Lee; Samuel N. Lockhart; Anne Murray; Katie E. Osborn; Melinda C. Power; Brittani R. Price; Hanneke F.M. Rhodius-Meester; Jacqueline A. Rondeau; Allyson C. Rosen; Douglas L. Rosene; Julie A. Schneider; Henrieta Scholtzova; C. Elizabeth Shaaban; Narlon C.B.S. Silva; Heather M. Snyder; Walter Swardfager; Aron M. Troen; Susanne J. van Veluw; Prashanthi Vemuri; Anders Wallin; Cheryl Wellington; Donna M. Wilcock; Sharon Xiangwen Xie; Atticus H. Hainsworth

doi:10.1016/j.trci.2019.02.001

White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities

Jessica Alber, Suvarna Alladi, Hee Joon Bae, David A. Barton, Laurel A. Beckett, Joanne M. Bell, Sara E. Berman, Geert Jan Biessels, Sandra E. Black, Isabelle Bos, Gene L. Bowman, Emanuele Brai, Adam M. Brickman, Brandy L. Callahan, Roderick A. Corriveau, Silvia Fossati, Rebecca F. Gottesman, Deborah R. Gustafson, Vladimir Hachinski, Kathleen M. HaydenAlex M. Helman, Timothy M. Hughes, Jeremy D. Isaacs, Angela L. Jefferson, Sterling C. Johnson, Alifiya Kapasi, Silke Kern, Jay C. Kwon, Juraj Kukolja, Athene Lee, Samuel N. Lockhart, Anne Murray, Katie E. Osborn, Melinda C. Power, Brittani R. Price, Hanneke F.M. Rhodius-Meester, Jacqueline A. Rondeau, Allyson C. Rosen, Douglas L. Rosene, Julie A. Schneider, Henrieta Scholtzova, C. Elizabeth Shaaban, Narlon C.B.S. Silva, Heather M. Snyder, Walter Swardfager, Aron M. Troen, Susanne J. van Veluw, Prashanthi Vemuri, Anders Wallin, Cheryl Wellington, Donna M. Wilcock, Sharon Xiangwen Xie, Atticus H. Hainsworth

School of Medicine

Research output: Contribution to journal › Short survey › peer-review

Abstract

White matter hyperintensities (WMHs) are frequently seen on brain magnetic resonance imaging scans of older people. Usually interpreted clinically as a surrogate for cerebral small vessel disease, WMHs are associated with increased likelihood of cognitive impairment and dementia (including Alzheimer's disease [AD]). WMHs are also seen in cognitively healthy people. In this collaboration of academic, clinical, and pharmaceutical industry perspectives, we identify outstanding questions about WMHs and their relation to cognition, dementia, and AD. What molecular and cellular changes underlie WMHs? What are the neuropathological correlates of WMHs? To what extent are demyelination and inflammation present? Is it helpful to subdivide into periventricular and subcortical WMHs? What do WMHs signify in people diagnosed with AD? What are the risk factors for developing WMHs? What preventive and therapeutic strategies target WMHs? Answering these questions will improve prevention and treatment of WMHs and dementia.

Original language	English (US)
Pages (from-to)	107-117
Number of pages	11
Journal	Alzheimer's and Dementia: Translational Research and Clinical Interventions
Volume	5
DOIs	https://doi.org/10.1016/j.trci.2019.02.001
State	Published - 2019

Keywords

Leukoaraiosis
Small vessel disease
Vascular cognitive impairment
Vascular dementia
White matter lesions

ASJC Scopus subject areas

Clinical Neurology
Psychiatry and Mental health

Access to Document

10.1016/j.trci.2019.02.001

Fingerprint Dive into the research topics of 'White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities'. Together they form a unique fingerprint.

Cite this

Alber, J., Alladi, S., Bae, H. J., Barton, D. A., Beckett, L. A., Bell, J. M., Berman, S. E., Biessels, G. J., Black, S. E., Bos, I., Bowman, G. L., Brai, E., Brickman, A. M., Callahan, B. L., Corriveau, R. A., Fossati, S., Gottesman, R. F., Gustafson, D. R., Hachinski, V., ... Hainsworth, A. H. (2019). White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 5, 107-117. https://doi.org/10.1016/j.trci.2019.02.001

White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID) : Knowledge gaps and opportunities. / Alber, Jessica; Alladi, Suvarna; Bae, Hee Joon; Barton, David A.; Beckett, Laurel A.; Bell, Joanne M.; Berman, Sara E.; Biessels, Geert Jan; Black, Sandra E.; Bos, Isabelle; Bowman, Gene L.; Brai, Emanuele; Brickman, Adam M.; Callahan, Brandy L.; Corriveau, Roderick A.; Fossati, Silvia; Gottesman, Rebecca F.; Gustafson, Deborah R.; Hachinski, Vladimir; Hayden, Kathleen M.; Helman, Alex M.; Hughes, Timothy M.; Isaacs, Jeremy D.; Jefferson, Angela L.; Johnson, Sterling C.; Kapasi, Alifiya; Kern, Silke; Kwon, Jay C.; Kukolja, Juraj; Lee, Athene; Lockhart, Samuel N.; Murray, Anne; Osborn, Katie E.; Power, Melinda C.; Price, Brittani R.; Rhodius-Meester, Hanneke F.M.; Rondeau, Jacqueline A.; Rosen, Allyson C.; Rosene, Douglas L.; Schneider, Julie A.; Scholtzova, Henrieta; Shaaban, C. Elizabeth; Silva, Narlon C.B.S.; Snyder, Heather M.; Swardfager, Walter; Troen, Aron M.; van Veluw, Susanne J.; Vemuri, Prashanthi; Wallin, Anders; Wellington, Cheryl; Wilcock, Donna M.; Xie, Sharon Xiangwen; Hainsworth, Atticus H.

In: Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 5, 2019, p. 107-117.

Research output: Contribution to journal › Short survey › peer-review

Alber, J, Alladi, S, Bae, HJ, Barton, DA, Beckett, LA, Bell, JM, Berman, SE, Biessels, GJ, Black, SE, Bos, I, Bowman, GL, Brai, E, Brickman, AM, Callahan, BL, Corriveau, RA, Fossati, S, Gottesman, RF, Gustafson, DR, Hachinski, V, Hayden, KM, Helman, AM, Hughes, TM, Isaacs, JD, Jefferson, AL, Johnson, SC, Kapasi, A, Kern, S, Kwon, JC, Kukolja, J, Lee, A, Lockhart, SN, Murray, A, Osborn, KE, Power, MC, Price, BR, Rhodius-Meester, HFM, Rondeau, JA, Rosen, AC, Rosene, DL, Schneider, JA, Scholtzova, H, Shaaban, CE, Silva, NCBS, Snyder, HM, Swardfager, W, Troen, AM, van Veluw, SJ, Vemuri, P, Wallin, A, Wellington, C, Wilcock, DM, Xie, SX & Hainsworth, AH 2019, 'White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities', Alzheimer's and Dementia: Translational Research and Clinical Interventions, vol. 5, pp. 107-117. https://doi.org/10.1016/j.trci.2019.02.001

Alber, Jessica ; Alladi, Suvarna ; Bae, Hee Joon ; Barton, David A. ; Beckett, Laurel A. ; Bell, Joanne M. ; Berman, Sara E. ; Biessels, Geert Jan ; Black, Sandra E. ; Bos, Isabelle ; Bowman, Gene L. ; Brai, Emanuele ; Brickman, Adam M. ; Callahan, Brandy L. ; Corriveau, Roderick A. ; Fossati, Silvia ; Gottesman, Rebecca F. ; Gustafson, Deborah R. ; Hachinski, Vladimir ; Hayden, Kathleen M. ; Helman, Alex M. ; Hughes, Timothy M. ; Isaacs, Jeremy D. ; Jefferson, Angela L. ; Johnson, Sterling C. ; Kapasi, Alifiya ; Kern, Silke ; Kwon, Jay C. ; Kukolja, Juraj ; Lee, Athene ; Lockhart, Samuel N. ; Murray, Anne ; Osborn, Katie E. ; Power, Melinda C. ; Price, Brittani R. ; Rhodius-Meester, Hanneke F.M. ; Rondeau, Jacqueline A. ; Rosen, Allyson C. ; Rosene, Douglas L. ; Schneider, Julie A. ; Scholtzova, Henrieta ; Shaaban, C. Elizabeth ; Silva, Narlon C.B.S. ; Snyder, Heather M. ; Swardfager, Walter ; Troen, Aron M. ; van Veluw, Susanne J. ; Vemuri, Prashanthi ; Wallin, Anders ; Wellington, Cheryl ; Wilcock, Donna M. ; Xie, Sharon Xiangwen ; Hainsworth, Atticus H. / White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID) : Knowledge gaps and opportunities. In: Alzheimer's and Dementia: Translational Research and Clinical Interventions. 2019 ; Vol. 5. pp. 107-117.

@article{c9812676be7c4fbcb650bbb23b1c48a7,

title = "White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities",

abstract = "White matter hyperintensities (WMHs) are frequently seen on brain magnetic resonance imaging scans of older people. Usually interpreted clinically as a surrogate for cerebral small vessel disease, WMHs are associated with increased likelihood of cognitive impairment and dementia (including Alzheimer's disease [AD]). WMHs are also seen in cognitively healthy people. In this collaboration of academic, clinical, and pharmaceutical industry perspectives, we identify outstanding questions about WMHs and their relation to cognition, dementia, and AD. What molecular and cellular changes underlie WMHs? What are the neuropathological correlates of WMHs? To what extent are demyelination and inflammation present? Is it helpful to subdivide into periventricular and subcortical WMHs? What do WMHs signify in people diagnosed with AD? What are the risk factors for developing WMHs? What preventive and therapeutic strategies target WMHs? Answering these questions will improve prevention and treatment of WMHs and dementia.",

keywords = "Leukoaraiosis, Small vessel disease, Vascular cognitive impairment, Vascular dementia, White matter lesions",

author = "Jessica Alber and Suvarna Alladi and Bae, {Hee Joon} and Barton, {David A.} and Beckett, {Laurel A.} and Bell, {Joanne M.} and Berman, {Sara E.} and Biessels, {Geert Jan} and Black, {Sandra E.} and Isabelle Bos and Bowman, {Gene L.} and Emanuele Brai and Brickman, {Adam M.} and Callahan, {Brandy L.} and Corriveau, {Roderick A.} and Silvia Fossati and Gottesman, {Rebecca F.} and Gustafson, {Deborah R.} and Vladimir Hachinski and Hayden, {Kathleen M.} and Helman, {Alex M.} and Hughes, {Timothy M.} and Isaacs, {Jeremy D.} and Jefferson, {Angela L.} and Johnson, {Sterling C.} and Alifiya Kapasi and Silke Kern and Kwon, {Jay C.} and Juraj Kukolja and Athene Lee and Lockhart, {Samuel N.} and Anne Murray and Osborn, {Katie E.} and Power, {Melinda C.} and Price, {Brittani R.} and Rhodius-Meester, {Hanneke F.M.} and Rondeau, {Jacqueline A.} and Rosen, {Allyson C.} and Rosene, {Douglas L.} and Schneider, {Julie A.} and Henrieta Scholtzova and Shaaban, {C. Elizabeth} and Silva, {Narlon C.B.S.} and Snyder, {Heather M.} and Walter Swardfager and Troen, {Aron M.} and {van Veluw}, {Susanne J.} and Prashanthi Vemuri and Anders Wallin and Cheryl Wellington and Wilcock, {Donna M.} and Xie, {Sharon Xiangwen} and Hainsworth, {Atticus H.}",

note = "Funding Information: D.A.B. is funded by National Health and Medical Research Council (Australia) . S.E.B. has funding from National Institutes of Health (NIH) / National Institute on Aging (NIA) (grant F30AG054115). G.J.B. acknowledges support from Vici (grant 918.16.616), from ZonMw, from The Netherlands Organisation for Health Research and Development, and from the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation (CVON 2012-06 Heart Brain Connection). G.L.B. reports US NIH / NIA funding. B.L.C. holds a Canada Research Chair. S.F. has NIH funding. T.M.H., K.M.H. and S.N.L. were supported by funding from the NIH ( P30 AG049638 ). J.K. is grateful for the support of the Marga and Walter Boll Foundation, Kerpen, Germany. M.C.P. has NIH and US DoD funding. C.E.S. was funded by National Institute on Aging (grant number F31 AG054084 ). A.M.T. was funded by Israel Science Foundation (grant 1353/11 ). C.W. is funded by the Weston Brain Institute , Canadian Institutes of Health Research (CIHR) and Cure Alzheimer's Fund . A.H.H. has funding from UK MRC ( MR/R005567/1 ), Alzheimer's Society (UK), and ADDF ( Ref. 20140901 ). ",

year = "2019",

doi = "10.1016/j.trci.2019.02.001",

language = "English (US)",

volume = "5",

pages = "107--117",

journal = "Alzheimer's and Dementia: Translational Research and Clinical Interventions",

issn = "2352-8737",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID)

T2 - Knowledge gaps and opportunities

AU - Alber, Jessica

AU - Alladi, Suvarna

AU - Bae, Hee Joon

AU - Barton, David A.

AU - Beckett, Laurel A.

AU - Bell, Joanne M.

AU - Berman, Sara E.

AU - Biessels, Geert Jan

AU - Black, Sandra E.

AU - Bos, Isabelle

AU - Bowman, Gene L.

AU - Brai, Emanuele

AU - Brickman, Adam M.

AU - Callahan, Brandy L.

AU - Corriveau, Roderick A.

AU - Fossati, Silvia

AU - Gottesman, Rebecca F.

AU - Gustafson, Deborah R.

AU - Hachinski, Vladimir

AU - Hayden, Kathleen M.

AU - Helman, Alex M.

AU - Hughes, Timothy M.

AU - Isaacs, Jeremy D.

AU - Jefferson, Angela L.

AU - Johnson, Sterling C.

AU - Kapasi, Alifiya

AU - Kern, Silke

AU - Kwon, Jay C.

AU - Kukolja, Juraj

AU - Lee, Athene

AU - Lockhart, Samuel N.

AU - Murray, Anne

AU - Osborn, Katie E.

AU - Power, Melinda C.

AU - Price, Brittani R.

AU - Rhodius-Meester, Hanneke F.M.

AU - Rondeau, Jacqueline A.

AU - Rosen, Allyson C.

AU - Rosene, Douglas L.

AU - Schneider, Julie A.

AU - Scholtzova, Henrieta

AU - Shaaban, C. Elizabeth

AU - Silva, Narlon C.B.S.

AU - Snyder, Heather M.

AU - Swardfager, Walter

AU - Troen, Aron M.

AU - van Veluw, Susanne J.

AU - Vemuri, Prashanthi

AU - Wallin, Anders

AU - Wellington, Cheryl

AU - Wilcock, Donna M.

AU - Xie, Sharon Xiangwen

AU - Hainsworth, Atticus H.

N1 - Funding Information: D.A.B. is funded by National Health and Medical Research Council (Australia) . S.E.B. has funding from National Institutes of Health (NIH) / National Institute on Aging (NIA) (grant F30AG054115). G.J.B. acknowledges support from Vici (grant 918.16.616), from ZonMw, from The Netherlands Organisation for Health Research and Development, and from the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation (CVON 2012-06 Heart Brain Connection). G.L.B. reports US NIH / NIA funding. B.L.C. holds a Canada Research Chair. S.F. has NIH funding. T.M.H., K.M.H. and S.N.L. were supported by funding from the NIH ( P30 AG049638 ). J.K. is grateful for the support of the Marga and Walter Boll Foundation, Kerpen, Germany. M.C.P. has NIH and US DoD funding. C.E.S. was funded by National Institute on Aging (grant number F31 AG054084 ). A.M.T. was funded by Israel Science Foundation (grant 1353/11 ). C.W. is funded by the Weston Brain Institute , Canadian Institutes of Health Research (CIHR) and Cure Alzheimer's Fund . A.H.H. has funding from UK MRC ( MR/R005567/1 ), Alzheimer's Society (UK), and ADDF ( Ref. 20140901 ).

PY - 2019

Y1 - 2019

N2 - White matter hyperintensities (WMHs) are frequently seen on brain magnetic resonance imaging scans of older people. Usually interpreted clinically as a surrogate for cerebral small vessel disease, WMHs are associated with increased likelihood of cognitive impairment and dementia (including Alzheimer's disease [AD]). WMHs are also seen in cognitively healthy people. In this collaboration of academic, clinical, and pharmaceutical industry perspectives, we identify outstanding questions about WMHs and their relation to cognition, dementia, and AD. What molecular and cellular changes underlie WMHs? What are the neuropathological correlates of WMHs? To what extent are demyelination and inflammation present? Is it helpful to subdivide into periventricular and subcortical WMHs? What do WMHs signify in people diagnosed with AD? What are the risk factors for developing WMHs? What preventive and therapeutic strategies target WMHs? Answering these questions will improve prevention and treatment of WMHs and dementia.

AB - White matter hyperintensities (WMHs) are frequently seen on brain magnetic resonance imaging scans of older people. Usually interpreted clinically as a surrogate for cerebral small vessel disease, WMHs are associated with increased likelihood of cognitive impairment and dementia (including Alzheimer's disease [AD]). WMHs are also seen in cognitively healthy people. In this collaboration of academic, clinical, and pharmaceutical industry perspectives, we identify outstanding questions about WMHs and their relation to cognition, dementia, and AD. What molecular and cellular changes underlie WMHs? What are the neuropathological correlates of WMHs? To what extent are demyelination and inflammation present? Is it helpful to subdivide into periventricular and subcortical WMHs? What do WMHs signify in people diagnosed with AD? What are the risk factors for developing WMHs? What preventive and therapeutic strategies target WMHs? Answering these questions will improve prevention and treatment of WMHs and dementia.

KW - Leukoaraiosis

KW - Small vessel disease

KW - Vascular cognitive impairment

KW - Vascular dementia

KW - White matter lesions

UR - http://www.scopus.com/inward/record.url?scp=85063999193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063999193&partnerID=8YFLogxK

U2 - 10.1016/j.trci.2019.02.001

DO - 10.1016/j.trci.2019.02.001

M3 - Short survey

C2 - 31011621

AN - SCOPUS:85063999193

VL - 5

SP - 107

EP - 117

JO - Alzheimer's and Dementia: Translational Research and Clinical Interventions

JF - Alzheimer's and Dementia: Translational Research and Clinical Interventions

SN - 2352-8737

ER -